Kestra Medical Technologies
KMTS
108 hedge funds and large institutions have $1.49B invested in Kestra Medical Technologies in 2026 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 55 increasing their positions, 20 reducing their positions, and 8 closing their positions.
175% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 20
88% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 8
27% more capital invested
Capital invested by funds: $1.17B → $1.49B (+$313M)
5% more funds holding
Funds holding: 103 → 108 (+5)
0.5% more ownership
Funds ownership: 100.1% → 100.61% (+0.5%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$11M |
| 2 |
Brown Advisory
Baltimore,
Maryland
|
+$3.88M |
| 3 |
BlackRock
New York
|
+$3.69M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$3.61M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$3.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$20.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.13M |
| 3 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
-$2.94M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$2.5M |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$2.18M |
KMTS Hedge Fund Activity: Q2 2026 in Review
108 of the 8,325 institutional investors tracked by Wall St. Rank reported a position in Kestra Medical Technologies (KMTS) for Q2 2026, worth a combined $1.49B — up 27% from $1.17B a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new KMTS positions and 8 closed out — a net gain of 7 holders — while 55 added to existing stakes and 20 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $11M. The largest seller was T. Rowe Price Associates, cutting an estimated $20.9M.
- 108 institutional investors held Kestra Medical Technologies (KMTS) as of Q2 2026, up from 103 in Q1 2026.
- Funds reported $1.49B of Kestra Medical Technologies stock for Q2 2026, up 27% quarter-over-quarter.
- 15 funds opened new Kestra Medical Technologies positions in Q2 2026 and 8 closed out, a net change of +7 holders.
- The largest Kestra Medical Technologies buyer in Q2 2026 was Point72 Asset Management, an estimated $11M added.
- The largest Kestra Medical Technologies seller in Q2 2026 was T. Rowe Price Associates, an estimated $20.9M sold.
Based on aggregated 13F filings for Q2 2026.